In those health centers that do not have geriatricians. The screening model is carri out, focus on the diagnosis of frailty. By the oncologist, through an abbreviat comprehensive geriatric evaluation. To recommend the st type of treatment for the patient considering the chances to achieve tter results. With minor risk of toxicities.Aging is associat with a decline. In the regenerative potential of stem cells. In recent years, several clinical trials have en launch in order to evaluate the efficacy. Of mesenchymal stem cell interventions to slow or reverse normal aging processes (aging conditions). Information concerning those clinical trials extract from national and international databases (US, EU, China, Japan. World Health Organization).
The Efficiency And Performance
This tool has proven to helpful in the diagnosis of conditions that are not evident. In a routine oncological evaluation, such as geriatric syndromes, frailty, functional dependence, and cognitive impairment among others. Which have an impact when deciding on therapy, pricting risks of treatment toxicity and mortality. In this article we aim to descri Costa Rica Email List the current situation of Oncogeriatrics and to provide epidemiological information about cancer in the elderly population in Chile attempting to highlight the importance of the Oncogeriatrics units, within cancer departments, for a tter decision taking in the elderly cancer patient. Introduction Aging is a well-recogniz risk factor in carcinogenesis (Hoffe and Balducci, 2012), directly involv in the expect increase of new cancer cases from 19 to more than 30 million by 2040 (International Agency for Research on Cancer, 2023). According to official information, 11.4% of the Chileans are 65 years or older.
Of Processes And Systems Ideas
With an expectancy of life of 76 years for men and 81 for women (Instituto Nacional de Estadísticas de Chile INE, 2023; International Agency for Research on Cancer, 2023) The elderly population in Chile accounts for 3,348,010 inhabitants, 1,861,067 females, and 1,468,943 males (Instituto Nacional de Estadísticas, 2023), 90% of them are part of the Chilean public system of health (FONASA, 2023), and the rest are treat in the Chilean private system of health (ISAPRES). Currently, cancer is the main cause of death in Chile. Unfortunately, local statistics were not initially design thinking of the definition of the geriatric population, therefore the report incidence of cancer for the group of 50–69 years is unique and does not allow to have confident numrs concerning the 60–69 years TH Lists subgroup. Also, there is a lack of an integrat national register of tumors, a situation that underestimates the real dimension of the cancer patient among the geriatric population.
